Federal Circuit Upholds Shire’s Patents for ADHD Drug September 30, 2015 The ruling blocks efforts by five drugmakers to market generic versions of Vyvanse. Read More
Medtronic Announces Availability of MiniMed Connect September 29, 2015 The device allows people with diabetes to view their insulin pump and continuous glucose monitoring information on a smartphone. Read More
Amgen Sues Hospira to Slow Marketing of Biosimilar September 29, 2015 Amgen alleges Hospira failed to disclose information on the manufacturing process of its biosimilar version of Epogen. Read More
FDA Approves Bayer HealthCare’s Betaconnect September 28, 2015 The electronic autoinjector is indicated for the treatment of relapsing-remitting multiple sclerosis. Read More
Gilead’s Hepatitis C Drug Combination Proves Effective in Clinical Trials September 28, 2015 The international Phase 3 trials monitored 1,302 patients with all genotypes of infection. Read More
Bolton Receives CE Mark Approval for Abdominal Stent-Graft System September 25, 2015 The system treats abdominal aortic aneurysms. Read More
Pfizer’s Xeljanz Meets Primary Endpoints in Two Phase 3 Trials September 25, 2015 Colitis sufferers taking Xeljanz twice daily saw increased remission. Read More
Bovie Signs GPO Agreement with Amerinet September 24, 2015 The agreement allows Amerinet members to access Bovie’s surgical product. Read More
Cempra Receives QIDP Designation for Taksta September 24, 2015 The drug treats acute bacterial skin and skin structure infections. Read More
St. Jude Receives CE Mark Approval for Deep Brain Stimulation System September 23, 2015 The system works on movement disorders. Read More
HHS to Collaborate With AstraZeneca for Biodefense Preparedness Plan September 23, 2015 The partnership will look to develop medications that could fight bioterrorism. Read More
FDA Grants 510(k) Clearance to Ceterix Orthopaedics for Meniscal Repair System September 22, 2015 Device aids in repairing horizontal, radia and other complex meniscal tears. Read More